The two health systems established the clinical trials through a four-year, $1.6 million grant awarded to UNMC by the National Institutes of Health.
Jessica Snowden, MD, an associate professor of pediatric infectious diseases at UNMC and Children’s, said the trials will cover a range of illnesses, including asthma, childhood obesity, prematurity and birth defects, among others, and will allow children from across the state to participate, according to the article.
Dr. Snowden said researchers do not yet know how many trials will be open, but that approximately 30 are ready to launch. Patients can begin to enroll in the trials beginning in November. Updates about the trials will be available on both health systems’ websites.
More articles on transactions and valuations:
Citizen’s Memorial Hospital, CoxHealth sign letter of intent
UMass Medical School joins NIH’s $5.5M precision partnership program
DuPage Medical Group acquires OB-GYN practice
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
